Ondas (ONDS) had the highest return between October 28, 2023 and December 31, 2023 by a mid-cap US stock, returning 320.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Ondas (ONDS) | 10/28/2023 - 12/31/2023 | 320.33% |
Pulse Biosciences (PLSE) | 10/28/2023 - 12/31/2023 | 190.05% |
ChronoScale (CHRN) | 10/28/2023 - 12/31/2023 | 185.16% |
Applied Opt (AAOI) | 10/28/2023 - 12/31/2023 | 170.59% |
Cytokinetics (CYTK) | 10/28/2023 - 12/31/2023 | 162.38% |
CleanSpark (CLSK) | 10/28/2023 - 12/31/2023 | 154.15% |
Xometry (XMTR) | 10/28/2023 - 12/31/2023 | 153.42% |
Sezzle (SEZL) | 10/28/2023 - 12/31/2023 | 151.79% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 10/28/2023 - 12/31/2023 | 148.36% |
TG Therapeutics (TGTX) | 10/28/2023 - 12/31/2023 | 144% |
Twist Bioscience (TWST) | 10/28/2023 - 12/31/2023 | 140.13% |
CareDx (CDNA) | 10/28/2023 - 12/31/2023 | 139.04% |
Nurix Therapeutics (NRIX) | 10/28/2023 - 12/31/2023 | 130.87% |
Iovance Biotherapeutics (IOVA) | 10/28/2023 - 12/31/2023 | 129.01% |
Kymera Therapeutics (KYMR) | 10/28/2023 - 12/31/2023 | 128.75% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 10/28/2023 - 12/31/2023 | 120.95% |
Aveanna Healthcare (AVAH) | 10/28/2023 - 12/31/2023 | 117.89% |
Kodiak Sciences (KOD) | 10/28/2023 - 12/31/2023 | 109.66% |
Dyne Therapeutics (DYN) | 10/28/2023 - 12/31/2023 | 107.81% |
Terawulf (WULF) | 10/28/2023 - 12/31/2023 | 106.9% |
Rhythm Pharmaceuticals (RYTM) | 10/28/2023 - 12/31/2023 | 106.61% |
TransMedics (TMDX) | 10/28/2023 - 12/31/2023 | 104.85% |
Ouster, Inc Common Stock (OUST) | 10/28/2023 - 12/31/2023 | 101.31% |
Spyre Therapeutics (SYRE) | 10/28/2023 - 12/31/2023 | 100% |
Newmark (NMRK) | 10/28/2023 - 12/31/2023 | 99.67% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.